The field of medicine, in particular medical imaging technology, is advancing rapidly.
The ESR aims to survey up-to-date information about the needs of the radiological research community to develop recommendations to enhance radiologists' involvement in the emerging fields of research and innovation.
In order to maintain and enhance research in radiology, the ESR makes continuous efforts to improve and advance education in radiology.
Leveraging cooperation between research disciplines and fostering networking with scientific biomedical societies in Europe and abroad are among the priority objectives of the ESR.
EIBIR is a non-profit organisation that supports biomedical imaging researchers. It offers expert advice along with proposal preparation services, and assumes project coordination, management and dissemination roles in international research projects.
EIBIR is currently involved in a number of research projects which are funded by a range of European grants, are industry initiated and supported, or are the result of an European Commission tender.
The ESR is pleased to announce that we have renewed our Memorandum of Understanding with the European Organisation for Research and Treatment of Cancer (EORTC). The main areas of cooperation include the organisation of joint sessions at the ECR and the increased involvement of radiologists in multicentre trials through the ESR’s European Imaging Biomarkers Alliance – EIBALL.
The EORTC is an independent, non-profit cancer research organisation. Its mission is to coordinate and conduct international translational and clinical research to improve the standard of cancer treatment for patients.
The ESR’s collaboration with the EORTC officially started in 2014, when the first Memorandum of Understanding was signed. Since then, 5 sessions (Professional Challenges and Joint Sessions) have been organised at the European Congress of Radiology (ECR) with the involvement of the EORTC, with the main aim of providing radiologists with information about the integration of imaging biomarkers in multicentre clinical oncological trials.
Biomarker standardisation/validation, imaging biobanks as well as radiogenomics are at the core of the cooperation between the ESR and the EORTC. For this reason the collaboration between the EORTC Imaging Group and the ESR’s EIBALL (European Imaging Biomarkers Alliance), a subcommittee of the ESR Research Committee, is fundamental in order to improve the inclusion of radiologists in multicentre trials.